Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma

William E. Fisher, Peter Muscarella, Laszlo G. Boros, William J. Schirmer

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Conclusion. Gastrointestinal hormones and their antagonists can alter the growth of pancreatic adenocarcinoma in vitro and in vivo. The potential clinical benefit of this approach deserves further study. Background. Epithelial cell growth is normally under hormonal control. Hormones also affect the growth of many epithelial cancers, and this fact is used to modify tumor growth. Pancreatic epithelial cell growth is under the influence of gastrointestinal hormones. This article reviews experiments designed to determine the effect of gastrointestinal hormones on the growth of pancreatic adenocarcinoma. Methods. Eighty-eight articles were identified from a Medline search using the terms pancreatic adenocarcinoma and the individual names of gastrointestinal hormones. The experimental design and results of these studies are reviewed. Results. In general, somatostatin, vasoactive intestinal polypeptide, pancreatic polypeptide, and pancreastatin inhibit pancreatic adenocarcinoma growth. Cholecystokinin, secretin, bombesin, gastrin, EGF, TGF-α, insulin, and IGF-1 have a growth-promoting effect.

Original languageEnglish (US)
Pages (from-to)169-180
Number of pages12
JournalInternational Journal of Pancreatology
Volume24
Issue number3
StatePublished - 1998
Externally publishedYes

Fingerprint

Gastrointestinal Hormones
Adenocarcinoma
Growth
Epithelial Cells
Hormone Antagonists
Pancreatic Polypeptide
Bombesin
Secretin
Vasoactive Intestinal Peptide
Cholecystokinin
Gastrins
Somatostatin
Insulin-Like Growth Factor I
Epidermal Growth Factor
Names
Neoplasms
Research Design
Hormones
Insulin

Keywords

  • Gastrointestinal hormones
  • Pancreatic adenocarcinoma

ASJC Scopus subject areas

  • Oncology
  • Endocrinology
  • Gastroenterology

Cite this

Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma. / Fisher, William E.; Muscarella, Peter; Boros, Laszlo G.; Schirmer, William J.

In: International Journal of Pancreatology, Vol. 24, No. 3, 1998, p. 169-180.

Research output: Contribution to journalReview article

Fisher, William E. ; Muscarella, Peter ; Boros, Laszlo G. ; Schirmer, William J. / Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma. In: International Journal of Pancreatology. 1998 ; Vol. 24, No. 3. pp. 169-180.
@article{573ccdb104c0433ebc7e162570ef701b,
title = "Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma",
abstract = "Conclusion. Gastrointestinal hormones and their antagonists can alter the growth of pancreatic adenocarcinoma in vitro and in vivo. The potential clinical benefit of this approach deserves further study. Background. Epithelial cell growth is normally under hormonal control. Hormones also affect the growth of many epithelial cancers, and this fact is used to modify tumor growth. Pancreatic epithelial cell growth is under the influence of gastrointestinal hormones. This article reviews experiments designed to determine the effect of gastrointestinal hormones on the growth of pancreatic adenocarcinoma. Methods. Eighty-eight articles were identified from a Medline search using the terms pancreatic adenocarcinoma and the individual names of gastrointestinal hormones. The experimental design and results of these studies are reviewed. Results. In general, somatostatin, vasoactive intestinal polypeptide, pancreatic polypeptide, and pancreastatin inhibit pancreatic adenocarcinoma growth. Cholecystokinin, secretin, bombesin, gastrin, EGF, TGF-α, insulin, and IGF-1 have a growth-promoting effect.",
keywords = "Gastrointestinal hormones, Pancreatic adenocarcinoma",
author = "Fisher, {William E.} and Peter Muscarella and Boros, {Laszlo G.} and Schirmer, {William J.}",
year = "1998",
language = "English (US)",
volume = "24",
pages = "169--180",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma

AU - Fisher, William E.

AU - Muscarella, Peter

AU - Boros, Laszlo G.

AU - Schirmer, William J.

PY - 1998

Y1 - 1998

N2 - Conclusion. Gastrointestinal hormones and their antagonists can alter the growth of pancreatic adenocarcinoma in vitro and in vivo. The potential clinical benefit of this approach deserves further study. Background. Epithelial cell growth is normally under hormonal control. Hormones also affect the growth of many epithelial cancers, and this fact is used to modify tumor growth. Pancreatic epithelial cell growth is under the influence of gastrointestinal hormones. This article reviews experiments designed to determine the effect of gastrointestinal hormones on the growth of pancreatic adenocarcinoma. Methods. Eighty-eight articles were identified from a Medline search using the terms pancreatic adenocarcinoma and the individual names of gastrointestinal hormones. The experimental design and results of these studies are reviewed. Results. In general, somatostatin, vasoactive intestinal polypeptide, pancreatic polypeptide, and pancreastatin inhibit pancreatic adenocarcinoma growth. Cholecystokinin, secretin, bombesin, gastrin, EGF, TGF-α, insulin, and IGF-1 have a growth-promoting effect.

AB - Conclusion. Gastrointestinal hormones and their antagonists can alter the growth of pancreatic adenocarcinoma in vitro and in vivo. The potential clinical benefit of this approach deserves further study. Background. Epithelial cell growth is normally under hormonal control. Hormones also affect the growth of many epithelial cancers, and this fact is used to modify tumor growth. Pancreatic epithelial cell growth is under the influence of gastrointestinal hormones. This article reviews experiments designed to determine the effect of gastrointestinal hormones on the growth of pancreatic adenocarcinoma. Methods. Eighty-eight articles were identified from a Medline search using the terms pancreatic adenocarcinoma and the individual names of gastrointestinal hormones. The experimental design and results of these studies are reviewed. Results. In general, somatostatin, vasoactive intestinal polypeptide, pancreatic polypeptide, and pancreastatin inhibit pancreatic adenocarcinoma growth. Cholecystokinin, secretin, bombesin, gastrin, EGF, TGF-α, insulin, and IGF-1 have a growth-promoting effect.

KW - Gastrointestinal hormones

KW - Pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0032408106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032408106&partnerID=8YFLogxK

M3 - Review article

VL - 24

SP - 169

EP - 180

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 3

ER -